4.7 Article

Bajijiasu Abrogates Osteoclast Differentiation via the Suppression of RANKL Signaling Pathways through NF-κB and NFAT

Related references

Note: Only part of the references are listed.
Article Cell Biology

Eriodictyol Inhibits RANKL-Induced Osteoclast Formation and Function Via Inhibition of NFATc1 Activity

Fangming Song et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2016)

Article Plant Sciences

Protective effects of bajijiasu in a rat model of Aβ25-35-induced neurotoxicity

Di-Ling Chen et al.

JOURNAL OF ETHNOPHARMACOLOGY (2014)

Article Biochemistry & Molecular Biology

HSP90 inhibitors enhance differentiation and MITF (microphthalmia transcription factor) activity in osteoclast progenitors

A. Gabrielle J. van der Kraan et al.

BIOCHEMICAL JOURNAL (2013)

Article Allergy

Critical Roles of IκB Kinase Subunits in Mast Cell Degranulation

Daiki Nakagomi et al.

INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2012)

Review Medicine, General & Internal

The future of osteoporosis treatment - a research update

Kurt Lippuner

SWISS MEDICAL WEEKLY (2012)

Article Biochemistry & Molecular Biology

Anthraquinone compounds from Morinda officinalis inhibit osteoclastic bone resorption in vitro

Leilei Bao et al.

CHEMICO-BIOLOGICAL INTERACTIONS (2011)

Article Medicine, General & Internal

Osteoporosis: now and the future

Tilman D. Rachner et al.

LANCET (2011)

Review Biochemistry & Molecular Biology

Glucocorticoids in osteonecrosis of the femoral head: A new understanding of the mechanisms of action

Mohammad Amin Kerachian et al.

JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2009)

Article Biochemistry & Molecular Biology

Inhibitory Effects of Morinda officinalis Extract on Bone Loss in Ovariectomized Rats

Nan Li et al.

MOLECULES (2009)

Article Medicine, Research & Experimental

NFATc1 in mice represses osteoprotegerin during osteoclastogenesis and dissociates systemic osteopenia from inflammation in cherubism

Antonios O. Aliprantis et al.

JOURNAL OF CLINICAL INVESTIGATION (2008)

Review Oncology

Key roles of the OPG-RANK-RANKL system in bone oncology

M. Baud'huin et al.

EXPERT REVIEW OF ANTICANCER THERAPY (2007)

Review Endocrinology & Metabolism

The molecular understanding of osteoclast differentiation

Masataka Asagiri et al.

Review Plant Sciences

Natural products as sources of new drugs over the last 25 years

David J. Newman et al.

JOURNAL OF NATURAL PRODUCTS (2007)

Article Immunology

Autoamplification of NFATc1 expression determines its essential role in bone homeostasis

M Asagiri et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2005)

Article Medicine, Research & Experimental

Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-regulated osteoclast differentiation

F Ikeda et al.

JOURNAL OF CLINICAL INVESTIGATION (2004)

Article Endocrinology & Metabolism

Role of osteoclast extracellular signal-regulated kinase (ERK) in cell survival and maintenance of cell polarity

H Nakamura et al.

JOURNAL OF BONE AND MINERAL RESEARCH (2003)

Review Multidisciplinary Sciences

Osteoclast differentiation and activation

WJ Boyle et al.

NATURE (2003)

Article Endocrinology & Metabolism

12-O-tetradecanoylphorbol-13-acetate (TPA) inhibits osteoclastogenesis by suppressing RANKL-induced NF-kappa B activation

C Wang et al.

JOURNAL OF BONE AND MINERAL RESEARCH (2003)

Article Endocrinology & Metabolism

Cloning, sequencing, and functional characterization of the rat homologue of receptor activator of NF-κB ligand

JK Xu et al.

JOURNAL OF BONE AND MINERAL RESEARCH (2000)